A carregar...
Targeted Therapies for Melanoma Brain Metastases
Brain metastases are a major clinical challenge occurring in up to 60% of patients suffering from metastatic melanoma. They cause significant clinical symptoms and impair the overall survival prognosis. The introduction of targeted therapies including BRAF and MEK inhibitors as well as CTLA-4 and PD...
Na minha lista:
Publicado no: | Curr Treat Options Neurol |
---|---|
Main Authors: | , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Springer US
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5378732/ https://ncbi.nlm.nih.gov/pubmed/28374234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11940-017-0449-2 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|